Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Lutronic LaseMD System for the Treatment of Melasma

NCT03456674 is registered in ClinicalTrials.gov with CynosureLutronic as lead sponsor.

NCT NCT03456674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03456674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Lutronic LaseMD System for the Treatment of Melasma
Lead sponsor
CynosureLutronic
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 7, 2018
Completion date
June 30, 2019
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melasma